Application of the H2FPEF score to a global clinical trial of patients with heart failure with preserved ejection fraction: the TOPCAT trial

Peder L. Myhre, Muthiah Vaduganathan, Brian L. Claggett, Carolyn S.P. Lam, Akshay S. Desai, Inder S. Anand, Nancy K. Sweitzer, James C. Fang, Eileen O'Meara, Sanjiv J. Shah, Amil M. Shah, Eldrin F. Lewis, Jean Rouleau, Bertram Pitt, Scott D. Solomon*

*Corresponding author for this work

Research output: Contribution to journalLetter

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)1288-1291
Number of pages4
JournalEuropean Journal of Heart Failure
Volume21
Issue number10
DOIs
StatePublished - Oct 1 2019

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Myhre, P. L., Vaduganathan, M., Claggett, B. L., Lam, C. S. P., Desai, A. S., Anand, I. S., Sweitzer, N. K., Fang, J. C., O'Meara, E., Shah, S. J., Shah, A. M., Lewis, E. F., Rouleau, J., Pitt, B., & Solomon, S. D. (2019). Application of the H2FPEF score to a global clinical trial of patients with heart failure with preserved ejection fraction: the TOPCAT trial. European Journal of Heart Failure, 21(10), 1288-1291. https://doi.org/10.1002/ejhf.1542